XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities:    
Net loss $ (47,139,000) $ (87,425,000)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 1,384,000 1,481,000
Amortization of internally developed software 9,162,000 11,030,000
Stock-based compensation expense 11,587,000 15,125,000
Deferred income taxes (17,010,000) (4,340,000)
Impairment charges 868,000 7,413,000
Other non-cash items (596,000) (43,000)
Changes in operating assets and liabilities:    
Accounts receivable 14,955,000 (1,871,000)
Contract assets – commissions receivable 92,811,000 104,582,000
Prepaid expenses and other assets (7,661,000) (9,896,000)
Accounts payable (17,111,000) (1,965,000)
Accrued compensation and benefits (19,621,000) (14,593,000)
Accrued marketing expenses (11,054,000) (11,132,000)
Deferred revenue (872,000) 861,000
Accrued expenses and other liabilities 901,000 69,000
Net cash provided by operating activities 10,604,000 9,296,000
Investing activities:    
Capitalized internal-use software and website development costs (10,785,000) (8,070,000)
Purchases of property and equipment and other assets (2,107,000) (1,463,000)
Purchases of marketable securities (74,010,000) (85,880,000)
Proceeds from redemption and maturities of marketable securities 105,950,000 39,000,000
Net cash provided by (used in) investing activities 19,048,000 (56,413,000)
Financing activities:    
Payment of deferred financing costs 1,000,000 0
Net proceeds from exercise of common stock options and employee stock purchases 189,000 354,000
Repurchase of shares to satisfy employee tax withholding obligations (2,102,000) (2,301,000)
Principal payments in connection with leases 0 (4,000)
Payments of preferred stock dividends (2,906,000) (2,740,000)
Net cash used in financing activities (5,819,000) (4,691,000)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 59,000 118,000
Net increase (decrease) in cash, cash equivalents and restricted cash 23,892,000 (51,690,000)
Cash, cash equivalents and restricted cash at beginning of period 42,287,000 118,812,000
Cash, cash equivalents and restricted cash at end of period $ 66,179,000 $ 67,122,000